Chemistry analyzers.
Active Awarded Last action
- Contract number
- HT001426FE022
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,401,075
Award facts
- Contract value 100% obligated
- $1,401,074.86 Current and potential, with all options
- Completion date 72% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Fort Belvoir, VA 22060, USA
Award details come from SAM.gov/FPDS.
About this award
Roche Diagnostics Corporation, headquartered in Indianapolis, Indiana, was awarded a $1.4 million firm fixed-price blanket purchase agreement call for chemistry analyzers by the Defense Health Agency on January 31, 2026. This contract is a child award under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration Schedule and carries an ultimate completion date of January 30, 2027. The work will be performed at Fort Belvoir, Virginia. As a leading supplier of in vitro diagnostic equipment and reagents to federal healthcare agencies, Roche Diagnostics provides comprehensive laboratory capabilities including clinical chemistry analysis systems, immunochemistry testing platforms, and associated consumables and maintenance services to military and defense healthcare facilities.
This award reflects continued federal demand for Roche's diagnostic analyzer technologies and supports the Defense Health Agency's laboratory operations. The contract was awarded without set-aside designation, indicating open competition in the federal marketplace. Roche maintains an extensive contracting footprint across the Defense Health Agency and Veterans Integrated Service Networks, with multiple active indefinite delivery contracts and blanket purchase agreements spanning laboratory automation systems, molecular diagnostics, histology services, and point-of-care testing solutions. This chemistry analyzer award aligns with the company's established role as a primary supplier of advanced diagnostic capabilities to the Department of Defense's military healthcare system.
Quick answers
Who was awarded contract HT001426FE022?
HT001426FE022 was awarded to Roche Diagnostics Corporation by Defense Health Agency (Department of Defense) on January 31, 2026.
How much is contract HT001426FE022 worth?
The government has obligated $1,401,075 on HT001426FE022.
Is contract HT001426FE022 an order under another contract?
Yes. HT001426FE022 is a BPA call under V797P7347A-HT001424A0003, a blanket purchase agreement, on Critical Analyzers, Laboratory (FSS-66-III).
Was contract HT001426FE022 competed?
The extent of competition for HT001426FE022 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award